▲ +28.34% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is $32.28, with a high forecast of $35.00 and a low forecast of $31.00. The average price target represents a 28.34% upside from the last price of $25.15.
The current consensus among 9 polled investment analysts is to buy stock in Sotera Health.
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the United States and internationally. Its sterilization services include gamma and electron beam irradiation, and EO processing; and lab services comprise analytical chemistry, medical device, and pharmaceutical lab testing, as well as microbiology testing. The company also provides Co-60 and gamma irradiators, which are principal components to the gamma sterilization process. Its microbiology testing services help customers to identify and measure the potential risks of microbes to a product and ensure that the quality of the products is maintained; and advisory services help customers in navigating the regulatory requirements applicable throughout the product lifecycle. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is based in Broadview Heights, Ohio.